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Background: Despite advances in therapeutic modalities, congenital diaphragmatic 
hernia (CDH) still accounts for significant neonatal mortality. This study aimed to 
describe the demographic features, clinical experiences of postnatal care, and 
differences between non-survivors and survivors with CDH.
Methods: We retrospectively reviewed medical records of neonates with CDH admit-
ted to Kaohsiung Chang Gung Memorial Hospital over a 21-year period. Neonates 
with diaphragmatic eventration and those transferred after surgery were excluded.
Results: A total of 24 live-born neonates fulfilled the study criteria; 13 (54%) were 
boys and 11 (46%) were girls. Eight (33%) patients were prenatally diagnosed. The 
mean gestational age was 38.8 ± 1.8 weeks (range, 35−41 weeks). Twenty-three 
(96%) had Bochdalek hernia [19 (83%) left-sided, 4 (17%) right-sided], and one (4%) 
had right-sided Morgagni hernia. Additional major congenital anomalies were iden-
tified in five patients (21%). The overall mortality was 21% (5/24); all deaths 
occurred before surgery. Statistically significant differences between survivors and 
non-survivors were found for right-sided CDH, low 1-minute and 5-minute Apgar 
scores, and low pH of the first arterial blood gas. Deaths were attributed to severe 
persistent pulmonary hypertension, unresponsiveness to aggressive resuscitation at 
birth, and major associated malformations.
Conclusion: Seventy-nine percent of our CDH patients survived to hospital dis-
charge. Resuscitation by a skilled neonatology team to prevent low Apgar scores 
and low pH, careful evaluation of other anomalies, and overcoming pulmonary 
hypertension might improve the survival rate. Recognizing unfavorable factors in 
CDH may help clinicians manage the critical care of these babies.
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1.  Introduction
Congenital diaphragmatic hernia (CDH) occurs in 1 in 
2500 to 4000 live births annually1,2 and is associated 
with significant morbidity and mortality. Neonates 
with this defect usually present with respiratory 
distress in the delivery room or soon after birth. 
These infants need intensive care in well-equipped 
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hospitals. The first successful repair of CDH in a ne-
onate within 24 hours of age was performed by 
Gross3 in 1946. With advances in neonatal care in 
the 1970s and 1980s, sick babies could survive to be 
transferred to a tertiary center. However, the mor-
tality in this era remained around 50%. New thera-
peutic modalities emerged in the following decades, 
including fetal intervention, gentle ventilation with 
permissive hypercapnia, inhaled nitric oxide (iNO), 
high-frequency oscillation ventilation (HFOV), ex-
tracorporeal membrane oxygenation (ECMO), and 
delayed surgical repair.4−8 The aims of this study 
were to describe the demographic features, pre-
operative course, and operative findings of these 
infants, and to analyze the variables that differ be-
tween non-survivors and survivors in neonates with 
CDH in a tertiary center over a 21-year period.
2.  Materials and Methods
We retrospectively reviewed the medical records 
of neonates with CDH admitted to Kaohsiung Chang 
Gung Memorial Hospital (KCGMH) between Febru-
ary 1987 and June 2008. Neonates with CDH were 
identified using the International Classification of 
Diseases (ICD 9 code 756.6, 553.3). Neonates with 
diaphragmatic eventration and those transferred 
after surgery were excluded. In our hospital, HFOV 
was introduced in October 1999, and iNO has been 
available since November 1999. Fetal surgery for 
CDH and ECMO was not available during the study 
period. Most cases of CDH were diagnosed by chest 
radiography, except one with right-sided CDH (RCDH) 
confirmed by chest computed tomography and one 
17 day-old infant with left-sided CDH (LCDH) who 
underwent gastrointestinal echography. The first 
arterial blood gases (ABG) were obtained just after 
birth or within the first 24 hours after patients 
became ill. The diagnostic criteria for persistent 
pulmonary hypertension of the neonate (PPHN) in-
cluded the following: (1) a gradient over 20% between 
preductal and postductal oximetry under mechani-
cal ventilation at a fraction of inspired oxygen of 
1.0, and (2) echocardiography demonstrating right-
to-left shunting across a patent foramen ovale or 
ductus arteriosus. Patients who developed PPHN re-
ceived intensive care during the period when HFOV 
and iNO were available. In patients who developed 
PPHN, HFOV was initially used as rescue therapy to 
increase oxygenation when conventional ventilation 
was ineffective. If HFOV failed to maintain an oxy-
genation index (mean airway pressure × fraction of 
inspired oxygen × 100/partial pressure of oxygen) of 
less than 20, iNO was used. However, iNO was not 
available for use in conjunction with HFOV during the 
study period. Repair of the CDH was performed in a 
delayed fashion once medical stability was achieved.
Univariate analyses of continuous and categorical 
variables were conducted using the Mann-Whitney 
test and χ2 or Fisher’s exact test, respectively. 
Multivariate analysis was performed by logistic re-
gression to adjust for potential confounding varia-
bles. Statistical analyses were performed using 
SPSS version 12.0 (SPSS Inc., Chicago, IL, USA) and 
p less than 0.05 was considered to be statistically 
significant.
3.  Results
A total of 24 live-born infants fulfilled the study 
criteria; 13 (54%) were boys and 11 (46%) were girls 
(Table 1). Eight (33%) patients had a prenatal diag-
nosis of CDH, at a mean gestational age of 28 weeks 
(range 22−38 weeks). Mean maternal age was 28.3 ± 
3.7 years (range 23−35 years). Most live-born ne-
onates with CDH (88%) were born at term; mean 
Table 1 Clinical variables associated with death in congenital diaphragmatic hernia patients
Variables Total (n = 24)* Survivors (n = 19)* Non-survivors (n = 5)* p
Right-sided hernia 5 (21) 2 (11) 3 (60)  0.040
Inborn 9 (38) 6 (32) 3 (60)  0.326
Prenatal diagnosis 8 (33) 5 (26) 3 (60)  0.289
PPHN 6 (25) 3 (16) 3 (60)  0.078
Major anomaly 5 (21) 4 (21) 1 (20)  1.000
Need for iNO 4 (17) 2 (11) 2 (40)  0.179
BBW (g) 3163 ± 398 3213 ± 335 2974 ± 593  0.499†
GA (wk) 38.8 ± 1.8 39.11 ± 1.59 38.8 ± 1.92  0.712†
pH of first ABG 7.17 ± 0.19 7.23 ± 0.12 6.93 ± 0.23 < 0.001†
1-min Apgar score 7.04 ± 2.48 7.84 ± 1.43 4.00 ± 3.39  0.010†
5-min Apgar score 8.42 ± 2.10 9.16 ± 1.01 5.60 ± 2.88  0.010†
*Values are expressed as n (%), or mean ± SD; †Mann-Whitney test. PPHN = persistent pulmonary hypertension of the neonate; 
iNO = inhaled nitric oxide; BBW = birth body weight; GA = gestational age; ABG = arterial blood gas.
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gestational age was 38.8 ± 1.8 weeks (range 35−41 
weeks), and the mean birth weight was 3163 ± 398 g 
(range 2340−3760 g). Age at admission ranged from 
0−28 days; 18 (75%) were admitted within 24 hours 
of birth, and 6 (27%) were more than 3 days old. 
Twenty-three (96%) had Bochdalek hernia [19 (83%) 
left-sided, four (17%) right-sided] and one (4%) had 
right-sided Morgagni hernia. Nine (38%) of the 24 
neonates were born in KCGMH. Mean duration of 
hospitalization was 20.2 ± 31.1 days (range 1−156 
days). The overall mortality was 21% (5/24); all 
deaths occurred before surgery.
3.1.  Associated defects
Fourteen patients had echocardiography examina-
tions. All but one had cardiac defects, the majority 
of which were minor defects (Table 2). Additional 
major congenital anomalies were identified in five 
patients (21%). These were single cases of Ebstein 
anomaly with pyloric hyperplasia, Ehlers-Danlos syn-
drome, complex heart disease (hypoplastic left heart 
syndrome, double-outlet right ventricle, coarctation 
of aorta, and severe mitral valve incompetence), 
extralobar lung sequestration, and Klippel-Feil 
syndrome.
3.2.  Preoperative course
Clinical presentation varied between the two groups 
of patients. One group consisted of 18 patients ad-
mitted within 24 hours of birth; all of whom had 
poor respiratory status with respiratory distress, 
weak crying, and cyanosis. Three patients had car-
diopulmonary collapse and required resuscitation 
before arrival at the neonatal intensive care unit. 
The other group consisted of six patients admitted 
after 3 days of age (mean 14 ± 9 days). Two of them 
presented with progressive tachypnea between 3 
and 5 days of age, three presented with combined 
tachypnea with acute-onset gastrointestinal com-
plaints, mainly vomiting or poor feeding, and one 
17 day-old patient presented with a 4-day history of 
vomiting without respiratory symptoms.
Five patients did not survive to operation. One 
patient responded poorly to initial cardiopulmonary 
resuscitation and died soon after birth. Three of six 
patients who developed PPHN died within 3 days, 
despite inotropic drugs, HFOV, and iNO (one pa-
tient’s parents refused) (Table 3). One patient died 
of complex heart disease at 22 days of age, before 
surgery could be performed.
3.3.  Operative findings
Nineteen of the 24 infants survived to receive lapa-
rotomy at a mean of 2.7 ± 1.9 days after admission 
Table 2  Associated defects in 24 patients with con-
genital diaphragmatic hernia
Type of defect n
Minor cardiac defects 13
 Patent ductus arteriosus 8
 Atrioseptal defect 7
 Patent foramen ovale 5
 Mild tricuspid regurgitation 4
Ebstein anomaly with pyloric hyperplasia 1
Ehlers-Danlos syndrome 1
Complex heart disease 1
Extralobar lung sequestration 1
Klippel-Feil syndrome 1
Table 3 Clinical features of six patients with persistent pulmonary hypertension
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1 Female Left 39 3060 6/8 7.162 Yes 44.1/100 18/78 72.7/40 Yes Survived
2 Male Right 36 2340 2/4 6.996 Yes 35.3/100 3/34 −/− No Expired
3 Male Left 41 3600 6/8 7.018 No 34.9/100 12/68 171.6/40 Yes Survived
4 Male Left 40 3760 0/5 6.939 No 48.3/100 2/23 −/− No Expired
5* Male Right 39 3150 7/8 7.010 No −/− 10/−* −/− No Expired
6 Male Left 37 2550 9/10 7.353 No −/− 27/0 −/− Yes Survived
*Patient whose parents refused iNO use. CDH = congenital diaphragmatic hernia; GA = gestational age; BBW = birth body weight; 
A/S (1′/5′) = Apgar score (1-minute/5-minute); ABG = arterial blood gas; FiO2 = fraction of inspired oxygen; HFOV = high-frequency 
oscillation ventilator; iNO = inhaled nitric oxide.
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(range 0−8 days). All these patients received primary 
repair, with 100% survival. A synthetic patch was 
used in one patient. The diameter of the diaphrag-
matic defect varied from 3−10 cm. A hernia sac was 
described in five patients (28%). Ten patients had 
surgery after 1998; six of these had no prophylactic 
chest tube placed in the ipsilateral hemithorax.
The most common herniated organs in LCDH 
were small bowel (88%) and large bowel (88%), fol-
lowed by spleen (81%) and stomach (59%). RCDH 
invariably contained liver (100%) and small bowel 
(100%) in our patients. One LCDH baby had a 4 × 
3 × 1-cm extralobar lung sequestration, which was 
excised uneventfully. The infant with Klippel-Feil 
syndrome also had hiatal hernia, and gastropexy 
was performed. Pyloric hyperplasia was found in 
the patient with Ehlers-Danlos syndrome, and py-
loromyotomy was performed. Fundoplication was 
also performed in this patient because of the large 
size of the hiatus.
Adhesion ileus was observed during postopera-
tive care in two patients, one at 1 month and the 
other at 16 months of age. They received enteroly-
sis. Difficult feeding was found in the patient with 
Klippel-Feil syndrome, who required jejunostomy 
at 3 months of age.
3.4.  Outcome analysis
Of 24 patients, five (21%) did not survive to surgery 
and accounted for all the deaths. The mortality of 
prenatally diagnosed patients was 38% (3/8) and 
of postnatally diagnosed patients was 12% (2/16). 
On univariate analysis, RCDH, low 1-minute and 
5-minute Apgar scores, and low pH of the first ABG 
differed significantly between survivors and non-
survivors (Table 1). Using multivariate analysis, no 
independent risk factor for mortality was identified 
in our study. HFOV and iNO were not included in 
the multiple logistic regression because they were 
used as rescue modalities in the treatment of criti-
cally ill patients.
4.  Discussion
In our study, the known postnatal mortality was 21% 
over a 21-year period. The true mortality of CDH 
comprises three categories.9 The first includes those 
diagnosed prenatally who are terminated or die 
in utero. Stege et al10 reported the termination rate 
(24%), spontaneous abortion rate (3%), and stillbirth 
rate (3%) in a geographically defined population 
during the 1990s. The second involves cases of hid-
den postnatal mortality, including babies with CDH 
who are delivered as live births, but who die be-
fore transfer to well-equipped centers. Pooled data 
from population-based studies suggests a hidden 
mortality of 34.9%.9 The third category is visible 
postnatal mortality, which includes babies with CDH 
admitted to a treatment center. The visible post-
natal mortality reported by the Congenital Dia-
phragmatic Hernia Study Group was 31% between 
1995 and 2004.11 Three single-center retrospective 
studies conducted in Taiwan by Chou et al,12 Chu 
et al,13 and Yao et al14 reported visible postnatal 
mortalities of 44%, 27%, and 38%, respectively. 
A national fetal and neonatal surveillance program 
is necessary to understand the true mortality of 
CDH in Taiwan.
Over 50% of CDH can be detected by prenatal 
ultrasonography at a mean gestational age of 24.2 
weeks, and approximately 70% of infants are deliv-
ered alive.15 For neonates with CDH referred to a 
treatment center, several studies have reported a 
significantly higher mortality in prenatally diagnosed 
patients, compared with those diagnosed postna-
tally (Stege et al:10 64% vs. 29%; Colvin et al:16 67% 
vs. 33%).10,16 In our series, eight babies (33%) were 
prenatally diagnosed, and the mortalities of pre-
natally and postnatally diagnosed patients were 38% 
and 12%, respectively. Prenatal diagnosis has the 
advantage of in utero transport and planned deliv-
ery in a tertiary center. However, prenatal diagno-
sis might imply a more severe or longer duration of 
visceral herniation, resulting in an increased degree 
of lung hypoplasia.16 The prenatal detection rate is 
also higher in CDH patients with other major mal-
formations, karyotype anomalies and syndromes, 
and this group has a poorer outcome.15,16
The great advance of ventilator strategies in the 
care of CDH babies is in reducing barotrauma through 
the concept of gentle ventilation and permissive 
hypercapnia proposed by Wung et al17 in 1985. We 
followed this principle with the majority of our pa-
tients, and none of them developed air-leak syn-
drome. The six patients who developed CDH-related 
pulmonary hypertension (PHT) were all admitted 
during the period when HFOV and iNO were avail-
able and used as rescue therapy at KCGMH; three 
of these patients survived. HFOV increases tissue 
oxygenation while minimizing barotrauma when 
conventional ventilation is ineffective. The Neonatal 
Inhaled Nitric Oxide Study Group reported the re-
sults of a randomized multicenter study on the use 
of iNO in CDH babies and found it did not reduce 
mortality or the need for ECMO.6 A study published 
by the Cochrane review in 2001 produced similar 
findings.18 None of our patients underwent fetal 
surgery or ECMO.
Approximately 80% of CDH occurred on the left 
side; the remainder were RCDH or bilateral. In our 
study, RCDH occurred in 21% (5/24) of patients, 
and only one patient was detected prenatally with 
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the aid of fetal magnetic resonance imaging. The 
prenatal diagnosis of RCDH is difficult because of 
the similar echogenicity of fetal lung and liver.19 
With the development of high-resolution ultrasound, 
color Doppler, and fetal magnetic resonance imag-
ing, accurate prenatal diagnosis has increased with 
benefits for prenatal surveillance and subsequent 
resuscitative efforts.20 Patients with RCDH were 
reported to have significantly higher mortality than 
those with LCDH.16,21 Three of the five patients 
with RCDH died in our study; the mortality of RCDH 
was significantly higher than that for those with 
LCDH (60% vs. 11%, p = 0.04). The causes of death 
in our RCDH patients were severe PHT in two cases 
(Table 3) and associated complex heart disease 
in one patient. Some investigators reported that 
RCDH had a higher rate of associated malforma-
tions than LCDH, but meta-analyses failed to iden-
tify any clear association between sidedness and 
major anomalies.9,22−24
Since Boix-Ochoa et al25 first reported differ-
ences in pH and PaCO2 between survivors and non-
survivors in 1974, several clinical parameters have 
been thought to affect survival.12,13,25,26 In our study, 
RCDH, low 1-minute and 5-minute Apgar scores, and 
low pH on the first ABG differed significantly be-
tween non-survivors and survivors (Table 1). Levison 
et al27 analyzed 242 patients and found three inde-
pendent risk factors for mortality with CDH: low 
5-minute Apgar score, prematurity, and air leak. 
Among these, 5-minute Apgar score was the strong-
est risk factor and may indicate an early marker of 
cardiopulmonary adaptation and response to resus-
citation. Several investigators have attempted to 
assess the degree of pulmonary hypoplasia by ABG 
and various ventilator parameters.26,28 The first ABG 
pH of in our study was found to be significantly 
lower in non-survivors on univariate analysis (p < 
0.001). The CDH study group analyzed 2524 neonates 
undergoing repair and reported that inborn status, 
gestational age less than 37 weeks, low birth weight 
(< 2 kg), prenatal diagnosis, major cardiac anomaly 
or chromosome anomaly, low 5-minute Apgar score, 
RCDH, and agenesis of diaphragm or defects need-
ing patch repair were significantly unfavorable fac-
tors for survival.11
This study reviewed clinical experiences in the 
care and short-term outcomes of CDH babies over a 
21-year period. Seventy-nine percent of the CDH ba-
bies survived to discharge. The causes of death were 
ascribed to severe persistent PHT, unresponsive-
ness to aggressive resuscitation at birth, and major 
associated malformations. All prenatally diagnosed 
patients should be referred to well-equipped hos-
pitals with multidisciplinary teams for prenatal coun-
seling and delicate postnatal medical and surgical 
treatment. Resuscitation in the delivery room by a 
skilled neonatology team, careful evaluation of other 
anomalies or dysmorphism, and ventilator mange-
ment to avoid barotrauma and to overcome PHT are 
essential in ensuring survival until surgical repair.
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